Neurobiology and temperament in the offspring of excellent lithium responders

References

• Akiskal HS, Akiskal KK, Haykal RF, Manning JS, Connor PD. 2005. TEMPS-A: progress towards validation of a self-rated clinical version of the Temperament Evaluation of the Memphis, Pisa, Paris, and San Diego Autoquestionnaire. J Affect Disord 85:3–16.
   PubMed Web of Science ®Google Scholar
• Dembinska-Krajewska D, Kliwicki S, Chlopocka-Wozniak M, Rybakowski J. 2012. The effectiveness of prophylactic use of lithium in bipolar disorder and schizotypal traits (in Polish). Pharmacother Psychiatry Neurol 28:153–158.
   Google Scholar
• Demidenko N, Grof P, Alda M, Deshauer D, Duffy A. 2004. MMPI as a measure of subthreshold and residual psychopathology among the offspring of lithium responsive and non-responsive bipolar parents. Bipolar Disord. 6:323–328.
   PubMedGoogle Scholar
• Domenici E, Willé DR, Tozzi F, Prokopenko I, Miller S, McKeown A, et al. 2010. Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections. PLoS One 5:e9166.
   PubMed Web of Science ®Google Scholar
• Duffy A, Alda M, Kutcher S, Fusee C, Grof P. 1998. Psychiatric symptoms and syndromes among adolescent children of parents with lithium-responsive or lithium-nonresponsive bipolar disorder. Am J Psychiatry. 155:431–433.
   PubMed Web of Science ®Google Scholar
• Duffy A, Alda M, Kutcher S, Cavazzoni P, Robertson C, Grof E, et al. 2002. A prospective study of the offspring of bipolar parents responsive and nonresponsive to lithium treatment. J Clin Psychiatry 63:1171–1178.
   PubMed Web of Science ®Google Scholar
• Duffy A, Horrocks J, Doucette S, Keown-Stoneman C, McCloskey S, Grof P. 2014. The developmental trajectory of bipolar disorder. Br J Psychiatry 204:122–128.
   PubMed Web of Science ®Google Scholar
• First MB, Spitzer RL, Gibbon M, Williams J. 1996. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV). Washington, DC: American Psychiatric Press Inc.
   Google Scholar
• Goodwin FK, Jamison KR. 2007. Manic-depressive illness: Bipolar disorders and recurrent depression. 2nd ed. Oxford: Oxford University Press.
   Google Scholar
• Grof P. 1998. Excellent lithium responders: People whose lives have been changed by lithium prophylaxis. In: Birch NJ, Gallicchio VS, Becker RW, editors. Lithium: 50 years of psychopharmacology. New Perspectives in Biomedical and Clinical Research. Cheshire, CT: Weidner Publishing Group. p 36–51.
   Google Scholar
• Grof P. 2010. Sixty years of lithium responders. Neuropsycho biology 62:27–35.
   PubMed Web of Science ®Google Scholar
• Grof P, Alda M, Grof E, Zvolsky P, Walsh M. 1994. Lithium response and genetics of affective disorders. J Affect Disord 32:85–95.
   PubMed Web of Science ®Google Scholar
• Grof P, Duffy A, Cavazzoni P, Grof E, Garnham J, MacDougall M, et al. 2002. Is response to prophylactic lithium a familial trait?J Clin Psychiatry 63:942–947.
   PubMed Web of Science ®Google Scholar
• Karam EG, Salamoun MM, Yeretzian JS, Mneimneh ZN, Karam AN, Fayyad J, et al. 2010. The role of anxious and hyperthymic temperaments in mental disorders: a national epidemiologic study. World Psychiatry 9:103–110.
   PubMed Web of Science ®Google Scholar
• Kauer-Sant’Anna M, Kapczinski F, Andreazza AC, Bond DJ, Lam RW, Young LT, et al. 2009. Brain derived neurotrophic factor and inflammatory markers in patients with early vs. late stage bipolar disorder. Int J Neuropsychopharmacol 12: 447–458.
   PubMed Web of Science ®Google Scholar
• Kraepelin E. 1899. Psychiatrie. Ein Lehrbuch für Studierende und Ärzte. 6 Auflage. Leipzig: Barth.
   Google Scholar
• Lapalme M, Hodgins S, LaRoche C. 1997. Children of parents with bipolar disorder: a metaanalysis of risk for mental disorders. Can J Psychiatry 42:623–631.
   PubMed Web of Science ®Google Scholar
• Mason O, Linney Y, Claridge G. 2005. Short scales for measuring schizotypy. Schizophr Res 78:293–296.
   PubMed Web of Science ®Google Scholar
• Passmore MJ, Garnham J, Duffy A, MacDougall M, Munro A, Slaney C, et al. 2003. Phenotypic spectra of bipolar disorder in responders to lithium versus lamotrigine. Bipolar Disord 5:110–114.
   PubMed Web of Science ®Google Scholar
• Post RM. 2007. Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications. J Psychiatr Res 41: 979–990.
   PubMed Web of Science ®Google Scholar
• Remlinger-Molenda A, Wójciak P, Michalak M, Rybakowski J. 2012a. Activity of selected cytokines in bipolar patients during manic and depressive episodes (In Polish). Psychiatr Pol 46:599–611.
   PubMed Web of Science ®Google Scholar
• Remlinger-Molenda A, Wojciak P, Michalak M, Karczewski J, Rybakowski JK. 2012b. Selected cytokine profiles during remission in bipolar patients. Neuropsychobiology 66:193–198.
   PubMed Web of Science ®Google Scholar
• Rybakowski JK, Chlopocka-Wozniak M, Suwalska A. 2001. The prophylactic effect of long-term lithium administration in bipolar patients entering treatment in the 1970s and 1980s. Bipolar Disord 3:63–67.
   PubMed Web of Science ®Google Scholar
• Rybakowski JK, Suwalska A, Skibinska M, Szczepankiewicz A, Leszczynska-Rodziewicz A, Permoda A, et al. 2005. Prophylactic lithium response and polymorphism of the brain-derived neurotrophic factor gene. Pharmacopsychiatry 38:166–170.
   PubMedGoogle Scholar
• Rybakowski JK. 2011. Lithium in neuropsychiatry: a 2010 update. World J Biol Psychiatry 12:340–348.
   PubMed Web of Science ®Google Scholar
• Rybakowski JK. 2013. Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge. CNS Drugs 27:165–173.
   PubMed Web of Science ®Google Scholar
• Rybakowski JK, Suwalska A. 2010. Excellent lithium responders have normal cognitive functions and plasma BDNF levels. Int J Neuropsychopharmacol 13:617–622.
   PubMed Web of Science ®Google Scholar
• Rybakowski JK, Permoda-Osip A, Borkowska A. 2009a. Response to prophylactic lithium in bipolar disorder may be associated with a preservation of executive cognitive functions. Eur Neuropsychopharmacol 19:791–795.
   PubMedGoogle Scholar
• Rybakowski JK, Skibinska M, Leszczynska-Rodziewicz A, Kaczmarek L, Hauser J. 2009b. Matrix metalloproteinase-9 gene and bipolar mood disorder. Neuromolecular Med 11:128–32.
   PubMedGoogle Scholar
• Rybakowski JK, Skibinska M, Suwalska A, Leszczynska- Rodziewicz A, Kaczmarek L, Hauser J. 2011. Functional polymorphism of matrix metalloproteinase-9 (MMP-9) gene and response to lithium prophylaxis in bipolar patients. Hum Psychopharmacol 26:168–171.
   PubMedGoogle Scholar
• Rybakowski JK, Czerski P, Dmitrzak-Weglarz M, Kliwicki S, Leszczynska-Rodziewicz A, Permoda-Osip A, et al. 2012. Clinical and pathogenic aspects of candidate genes for lithium prophylactic efficacy. J Psychopharmacol 26:368–373.
   PubMedGoogle Scholar
• Rybakowski JK, Dembinska D, Kliwicki S, Akiskal KK, Akiskal HH. 2013a. TEMPS-A and long-term lithium response: positive correlation with hyperthymic temperament. J Affect Disord 20;145:187–189.
   PubMed Web of Science ®Google Scholar
• Rybakowski JK, Remlinger-Molenda A, Czech-Kucharska A, Wojcicka M, Michalak M, Losy J. 2013b. Increased serum matrix metalloproteinase-9 (MMP-9) levels in young patients during bipolar depression. J Affect Disord 146:286–289.
   PubMed Web of Science ®Google Scholar
• Schurhoff F, Laguerre A, Szoke A, Meary A, Leboyer M. 2005. Schizotypal dimensions: continuity between schizophrenia and bipolar disorders. Schizophr Res 80:235–242.
   PubMedGoogle Scholar